Circulation. Cardiovascular interventions
-
Circ Cardiovasc Interv · Jun 2013
Randomized Controlled Trial Comparative StudyComparison of manual thrombus aspiration with rheolytic thrombectomy in acute myocardial infarction.
Manual thrombus aspiration (MTA) is completely ineffective in 30% of cases, and the high profiles of the catheters prevent their use in tortuous and calcified vessels. The rheolytic thrombectomy (RT) device has the potential for improved thrombus removal in acute myocardial infarction as compared with MTA. No data exist on the comparison between the 2 techniques. ⋯ URL: http://www.clinicaltrials.gov. Unique identifier: NCT01281033.
-
Circ Cardiovasc Interv · Jun 2013
Randomized Controlled TrialRemote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
Postprocedural myocardial infarction (type 4a) has been shown to be an adverse prognostic indicator after elective percutaneous coronary intervention (PCI). The Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) study demonstrated that remote ischemic preconditioning reduced procedural symptoms, ECG ST-segment deviation, and cardiac troponin I release after elective PCI and reduced the major adverse cardiac and cerebral event (MACCE) rate at 6 months. We were interested to confirm if this early benefit in MACCE rate in the remote ischemic preconditioning group was sustained long-term. ⋯ URL: http://www.ukcrn.org.uk. Unique identifier: UKCRN 4074.
-
Circ Cardiovasc Interv · Jun 2013
Transcatheter aortic valve implantation for patients with severe bicuspid aortic valve stenosis.
Bicuspid aortic valve (BAV) is regarded as a relative contraindication to transcatheter aortic valve implantation attributable to the risk of uneven expansion of the bioprosthesis. The purpose of this study was to evaluate the efficacy and safety of transcatheter aortic valve implantation in patients with BAV. ⋯ In selected BAV patients, transcatheter aortic valve implantation may be associated with low complication rate, efficacy, and acceptable outcomes similar to those in non-BAV patients.